NOVNQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NOVNQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Debt-to-EBITDA measures a company's ability to pay off its debt.
NVN Liquidation's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $0.47 Mil. NVN Liquidation's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $3.39 Mil. NVN Liquidation's annualized EBITDA for the quarter that ended in Mar. 2023 was $-51.60 Mil. NVN Liquidation's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2023 was -0.07.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's
The historical rank and industry rank for NVN Liquidation's Debt-to-EBITDA or its related term are showing as below:
The historical data trend for NVN Liquidation's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NVN Liquidation Annual Data | |||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | ||||||||||
Debt-to-EBITDA | Get a 7-Day Free Trial | -0.30 | -0.22 | -0.04 | -0.12 | -0.15 |
NVN Liquidation Quarterly Data | ||||||||||||||||||||
Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | |
Debt-to-EBITDA | Get a 7-Day Free Trial | -0.40 | -0.68 | -0.23 | -0.47 | -0.08 |
For the Biotechnology subindustry, NVN Liquidation's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, NVN Liquidation's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where NVN Liquidation's Debt-to-EBITDA falls into.
Debt-to-EBITDA measures a company's ability to pay off its debt.
NVN Liquidation's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as
Debt-to-EBITDA | = | Total Debt | / | EBITDA | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | EBITDA | |
= | (0.191 | + | 3.739) | / | -27.081 | |
= | -0.15 |
NVN Liquidation's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2023 is calculated as
Debt-to-EBITDA | = | Total Debt | / | EBITDA | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | EBITDA | |
= | (0.465 | + | 3.387) | / | -51.596 | |
= | -0.07 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2023) EBITDA data.
NVN Liquidation (OTCPK:NOVNQ) Debt-to-EBITDA Explanation
In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.
Be Aware
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's
Thank you for viewing the detailed overview of NVN Liquidation's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Machelle Sanders | director | C/O NOVAN, INC., 4105 HOPSON ROAD, MORRISVILLE NC 27560 |
James L Bierman | director | 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA 23116 |
John W Palmour | director | C/O CREE, INC., 4600 SILICON DRIVE, DURHAM NC 27703 |
John M. Gay | officer: VP, Finance & Corp. Controller | C/O NOVAN, INC., 4105 HOPSON ROAD, MORRISVILLE NC 27560 |
A. Donofrio John | officer: EVP, Chief Operating Officer | C/O NOVAN, INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM NC 27703 |
Paula B Stafford | director | C/O NOVAN, INC., 4105 HOPSON ROAD, MORRISVILLE NC 27560 |
Steven D Skolsky | director | TRIMERIS, INC., 3500 PARAMOUNT PARKWAY, MORRISVILLE NC 27560 |
Malin Life Sciences Holdings Ltd | 10 percent owner | 2 HARBOUR SQUARE, CROFTON ROAD, DUN LAOGHAIRE, CO, DUBLIN L2 ---- |
G. Kelly Martin | director | C/O NOVAN, INC., 4105 HOPSON RD, MORRISVILLE NC 27560 |
Robert Alexander Ingram | director | 280 S. MANGUM STREET, SUITE 350, DURHAM NC 27701 |
W Kent Geer | director | 7104 RAINWATER ROAD, RALEIGH NC 27615 |
Andrew Novak | officer: Chief Accounting Officer | C/O NOVAN, INC., 4105 HOPSON ROAD, MORRISVILLE NC 27560 |
Eugene Sun | director | C/O NOVAN, INC., 4105 HOPSON ROAD, MORRISVILLE NC 27560 |
James H. Goodnight Management Trust | 10 percent owner | 100 SAS CAMPUS DRIVE, CARY NC 27513 |
Donald R Parker | 10 percent owner | 100 SAS CAMPUS DRIVE, CARY NC 27513 |
From GuruFocus
By Value_Insider Value_Insider • 10-14-2022
By GuruFocusNews GuruFocusNews • 06-28-2022
By PurpleRose PurpleRose • 07-13-2022
By GuruFocusNews GuruFocusNews • 07-05-2022
By sperokesalga sperokesalga • 05-08-2023
By GuruFocusNews GuruFocusNews • 07-09-2022
By PurpleRose PurpleRose • 07-15-2022
By sperokesalga sperokesalga • 03-30-2023
By sperokesalga sperokesalga • 03-23-2023
By sperokesalga sperokesalga • 05-31-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.